Published in Health Business Week, December 15th, 2006
PERCIVIA was conceived and designed to further develop the PER.C6 cell line and provide turnkey solutions for the production of pharmaceutical proteins to licensees utilizing the PER.C6 human cell line in the biotech industry - currently a US$35 billion industry.
"PERCIVIA's state-of-the-art facility will generate the know-how and support for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.